You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited (D. Del. 2022)

Docket	⤷ Sign Up	Date Filed	2022-04-08
Court	District Court, D. Delaware	Date Terminated	2024-05-30
Cause	35:271 Patent Infringement	Assigned To	Jennifer L. Hall
Jury Demand	None	Referred To
Parties	H. LUNDBECK A/S
Patents	10,525,057; 7,807,680; 8,030,313; 8,338,427; 8,399,469; 8,722,679
Attorneys	Christine Dealy Haynes
Firms	Richards, Layton & Finger, PA
Link to Docket	External link to docket

Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2023-09-12	144	Report and Recommendations	,469 (the “’469 patent”), 10,525,057 (the “’057 patent”), 10,980,803 (the “’803 patent”), 11,154,553…across seven patents. The seven patents are U.S. Patent Nos. 8,338,427 (the “’427 patent”), 8,399,469… (the “’553 patent”), 11,344,547 (the “’547 patent”), and 11,400,087 (the “’087 patent”). I held … patent, claims 1, 10, and 25; ’547 patent, claims 1, 7, and 16; ’087 patent, claims 1… the ’803 patent. 16 The ’803 patent is a continuation of the ’057 patent and shares	External link to document
2024-02-13	222	Notice of Service	Invalidity of The Cyp Method of Treatment Patents (U.S. Patent Nos. 10,525,057, 10,908,803, 11,154,553, 11,344,…Invalidity of The Cyp Method of Treatment Patents (U.S. Patent Nos. 10,525,057, 10,908,803, 11,154,553, 11,344,… Jonathan W. Steed Regarding Invalidity of U.S. Patent No. 8,399,469 [Highly Confidential], and Opening… 2022 30 May 2024 1:22-cv-00464 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2024-04-12	253	Notice of Service	Invalidity of the CYP Method of Treatment Patents (U.S. Patent Nos. 10,525,057, 10,908,803, 11,154,553, 11,344,…Invalidity of the CYP Method of Treatment Patents (U.S. Patent Nos. 10,525,057, 10,908,803, 11,154,553, 11,344,… Jonathan W. Steed Regarding Invalidity of U.S. Patent No. 8,399,469; 4) Expert Report of Dr. Yaning Wang… 2022 30 May 2024 1:22-cv-00464 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2024-05-30	303	Patent/Trademark Report to Commissioner of Patents	,030,313; 8,338,427; 8,399,469; 8,722,679; 10,525,057; 10,980,803; 11,154,553. (Attachments: # 1 Stipulation… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,807,680; 8,030,313… 2022 30 May 2024 1:22-cv-00464 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.